Yan Wu Selected Research

human MIRN1229 microRNA

11/2021

miR-1229-3p as a Prognostic Predictor Facilitates Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Wu Research Topics

Disease

309	Neoplasms (Cancer) 11/2022 - 05/2002
86	Inflammation (Inflammations) 06/2022 - 08/2004
49	Infections 08/2022 - 01/2003
45	Neoplasm Metastasis (Metastasis) 06/2022 - 06/2004
35	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2005
28	Fibrosis (Cirrhosis) 06/2022 - 07/2006
28	Breast Neoplasms (Breast Cancer) 04/2021 - 09/2002
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 02/2013
26	Lung Neoplasms (Lung Cancer) 07/2022 - 10/2003
25	Hypoxia (Hypoxemia) 01/2022 - 10/2004
24	Stomach Neoplasms (Stomach Cancer) 05/2022 - 07/2011
21	Carcinogenesis 11/2021 - 10/2003
20	Body Weight (Weight, Body) 10/2022 - 11/2010
20	Wounds and Injuries (Trauma) 05/2022 - 01/2000
18	Carcinoma (Carcinomatosis) 12/2021 - 01/2003
17	COVID-19 08/2022 - 01/2020
17	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 01/2009
17	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2022 - 01/2004
17	Melanoma (Melanoma, Malignant) 08/2021 - 01/2007
15	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2005
15	Heart Failure 01/2021 - 03/2005
14	Necrosis 01/2020 - 11/2004
13	Hypertension (High Blood Pressure) 04/2022 - 07/2005
13	Human Influenza (Influenza) 01/2021 - 04/2006
12	Myocardial Infarction 02/2022 - 01/2013
12	Endometriosis 01/2022 - 08/2005
12	Sepsis (Septicemia) 01/2022 - 01/2016
12	Ischemia 01/2022 - 05/2006
11	Neuroinflammatory Diseases 05/2022 - 08/2012
11	Pneumonia (Pneumonitis) 01/2022 - 04/2009
11	Vitiligo 01/2021 - 01/2015
10	Hemorrhage 10/2022 - 02/2010
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2000
10	Cognitive Dysfunction 01/2022 - 11/2013
10	Reperfusion Injury 11/2021 - 04/2010
10	Infarction (Infarctions) 01/2020 - 09/2011
9	Stroke (Strokes) 10/2022 - 03/2012
9	Disease Progression 01/2022 - 08/2002
9	Pain (Aches) 01/2022 - 04/2006
9	Atherosclerosis 01/2022 - 08/2002
9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2018
9	Erythema 12/2021 - 11/2008

Drug/Important Bio-Agent (IBA)

78	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2002
66	Pharmaceutical PreparationsIBA 10/2022 - 08/2007
48	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2007
41	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2009
38	Messenger RNA (mRNA)IBA 01/2022 - 01/2004
34	CytokinesIBA 05/2022 - 04/2006
32	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2003
27	Biological ProductsIBA 04/2022 - 01/2003
22	LigandsIBA 11/2022 - 01/2004
22	EnzymesIBA 01/2022 - 02/2004
21	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 09/2008
20	AntibodiesIBA 03/2022 - 11/2004
18	ErbB Receptors (EGF Receptor)IBA 11/2022 - 07/2009
18	LipidsIBA 06/2022 - 01/2009
17	VaccinesIBA 08/2022 - 04/2006
17	Therapeutic UsesIBA 03/2022 - 04/2007
16	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021 - 11/2011
16	CollagenIBA 01/2021 - 11/2004
15	Phosphotransferases (Kinase)IBA 08/2022 - 07/2005
14	Hyaluronic Acid (Hyaluronan)IBA 05/2021 - 07/2007
13	Epidermal Growth Factor (EGF)IBA 11/2022 - 02/2012
13	Antiviral Agents (Antivirals)IBA 08/2022 - 01/2016
13	Interleukin-6 (Interleukin 6)IBA 03/2022 - 02/2004
13	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2007
12	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2010
12	AntigensIBA 11/2022 - 04/2002
12	Long Noncoding RNAIBA 01/2022 - 01/2019
12	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 03/2012
12	Peptides (Polypeptides)IBA 12/2021 - 05/2011
12	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 02/2011 - 11/2004
11	Protein Kinases (Protein Kinase)IBA 05/2022 - 09/2008
11	AcidsIBA 03/2021 - 01/2013
11	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 04/2010
11	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2011
11	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2009
10	oxidized low density lipoproteinIBA 04/2022 - 03/2013
10	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 08/2012
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2006
10	SolutionsIBA 05/2020 - 10/2008
10	Adenosine Triphosphate (ATP)IBA 01/2020 - 09/2008
10	Monoclonal AntibodiesIBA 01/2019 - 04/2002
9	CurcuminIBA 06/2022 - 07/2014
9	Oxygen (Dioxygen)IBA 01/2022 - 10/2004
9	Indicators and Reagents (Reagents)IBA 11/2021 - 03/2006
9	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2021 - 12/2013
9	Bleomycin (Blenoxane)FDA LinkGeneric 05/2020 - 06/2009

Therapy/Procedure

160	Therapeutics 07/2022 - 10/2003
45	Drug Therapy (Chemotherapy) 01/2022 - 07/2006
29	Immunotherapy 01/2022 - 01/2005
20	Lasers (Laser) 08/2022 - 01/2006
16	Photothermal Therapy 08/2021 - 12/2012
14	Transplantation 01/2021 - 02/2004
12	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 10/2015
10	Radiotherapy 01/2022 - 07/2006
10	Aftercare (After-Treatment) 01/2022 - 03/2005
10	Precision Medicine 08/2021 - 10/2016
10	Ligation 01/2020 - 07/2008
9	Photochemotherapy (Photodynamic Therapy) 03/2021 - 12/2013